NetPass
Please enter the answers only  for the sections that you wish to complete and receive credit.
 After you have answered the questions for the sections that you wish to complete,simply click Check Answers to proceed.
 
Self-Assessment Answers for Section 1: ER/Opioid REMS Education
1 . Long-acting (LA) and extended-release (ER) formulations of opioids should typically not be used for which of the following?
A.
B.
C.
D.
2 . If an organic pathology cannot be found to explain a patient’s pain, what should a clinician infer?
A.
B.
C.
D.
3 . Which of the following is the appropriate use of “universal precautions” as it applies to patients with chronic pain?
A.
B.
C.
4 . The DIRE and the COMM are examples of which of the following assessments?
A.
B.
C.
D.
5 . All of the following need to be documented in writing as part of an overall therapeutic approach to managing chronic pain patients EXCEPT:
A.
B.
C.
D.
6 . All of the following are possible advantages of patient/provider agreements EXCEPT:
A.
B.
C.
D.
7 . All of the following are examples of functional goals EXCEPT:
A.
B.
C.
D.
8 . The responsibility for obtaining evidence of success in meeting a functional goal lies with which of the following individuals?
A.
B.
C.
D.
9 . All of the following are reasonable causes for discontinuing treatment with an opioid medication EXCEPT:
A.
B.
C.
D.
10 . When opioid treatment is initiated, both the patient and clinician should view the commitment as:
A.
B.
C.
D.
11 . It can be particularly unsafe to combine opioids with which of the following other medicines?
A.
B.
C.
D.
12 . The duration of action of short-acting opioids is generally:
A.
B.
C.
D.
13 . Short-acting opioids are most appropriate and commonly used for which of the following conditions?
A.
B.
C.
D.
14 . Combination products are those that include an opioid with which of the following elements?
A.
B.
C.
D.
15 . What is the typical duration of action of the different ER/LA opioids?
A.
B.
C.
D.
16 . All of the following are of particular concern when prescribing an ER/LA opioid pain medication EXCEPT:
A.
B.
C.
D.
17 . All of the following types of patients need more frequent or intense monitoring EXCEPT:
A.
B.
C.
D.
18 . Of the following tools, which one can help patients pinpoint triggers of breakthrough pain?
A.
B.
C.
D.
19 . Uncomfortable or unpleasant side effects (aside from constipation) may potentially be reduced by which two approaches?
A.
B.
C.
D.
20 . All of the following are valid reasons to pursue opioid rotation EXCEPT:
A.
B.
C.
D.
21 . Which of the following is the APS-AAPM guideline regarding driving for patients prescribed opioid medication?
A.
B.
C.
D.
22 . One reason that methadone must be prescribed with particular caution is that:
A.
B.
C.
D.
23 . In 2006, the FDA added a caution to the “black box” warning that methadone may cause which of the following serious adverse effects?
A.
B.
C.
D.
InforMed